FeesSafety
Pluang+

Institutional interest in Bitcoin rises as VCs regret missing early investment opportunities.

Market News
04 Nov 2026, 18:31 WIB
Zycrypto
View Source
Bullish
Institutional interest in Bitcoin rises as VCs regret missing early investment opportunities.

Tom Lee, Fundstrat's CIO and Bitmine's chairman, highlights growing institutional interest in Bitcoin, noting venture capitalists regret not investing earlier when Bitcoin was under $1,000. Bitcoin's price surged to around $80,000, delivering an 80x return over ten years. Lee encourages investors to consider buying Bitcoin, Ethereum, and Solana, emphasizing that most investors still lack exposure to Bitcoin and that now is a good time to invest in these cryptocurrencies for potential long-term gains.

Tom Lee's comments on Bitcoin and cryptocurrencies provide context for Pluang's market snapshot as of Nov 04, 2026 23:32 WIB: out of 50 major cryptocurrencies priced on Pluang, 47 rose and 2 fell today. Among notable movers, EOS gained 8.13% to Rp12.649 with a typical hold time of 87 days, while CRV rose 6.66% to Rp5.042 despite a 63% sell order activity, and ALGO increased 6.23% to Rp1.808 with a longer typical hold time of 131 days.

More News

Good Life Meds must stop unproven health and personalization claims for compounded Tirzepatide+ products.

Good Life Meds must stop unproven health and personalization claims for compounded Tirzepatide+ products.

The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...

Market News
Bearish
58 minutes ago
Moleculin's Annamycin shows promising remission rates in AML trial, data to be presented at ASH 2026.

Moleculin's Annamycin shows promising remission rates in AML trial, data to be presented at ASH 2026.

Moleculin Biotech announced that interim results from its Phase 2/3 trial of Annamycin for relapsed or refractory acute myeloid leukemia (AML) will be presented at the 2026 ASH Annual Meeting. The trial showed remission rates of 43% and 36% in two An...

Company Fundamentals
Bullish
58 minutes ago
ANZ dental implants market to grow 5% CAGR, reaching $393M by 2033 driven by aging population and prosthetic demand

ANZ dental implants market to grow 5% CAGR, reaching $393M by 2033 driven by aging population and prosthetic demand

The Australia and New Zealand (ANZ) dental implants market, valued at $266 million in 2025, is projected to grow at a 5% CAGR to $393 million by 2033. Growth is driven by increasing demand for oral rehabilitation and prosthetic dentistry, especially ...

Market News
Bullish
58 minutes ago
New study shows Asgard's tech induces cancer-fighting structures in tumors, boosting therapy success across 7 cancer types.

New study shows Asgard's tech induces cancer-fighting structures in tumors, boosting therapy success across 7 cancer types.

Asgard Therapeutics published a study in Immunity demonstrating its technology can reprogram tumor cells into dendritic cells, inducing cancer-fighting tertiary lymphoid structures (imgTLSs) across seven tumor types. This tumor-agnostic approach led ...

Others
Bullish
58 minutes ago
Cap expands onchain credit marketplace to finance film production without tokenizing assets

Cap expands onchain credit marketplace to finance film production without tokenizing assets

Cap, an onchain credit marketplace, is expanding into film and media financing by providing funding for the upcoming film Wake. This deal uses advances against anticipated film production tax credits, showing how Cap's underwriting model supports spe...

Market News
Bullish
58 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App